Understanding SARS-CoV-2 associated immune pathology is crucial to develop pan- effective vaccines and treatments. Here we investigate the immune events from the acute …
C Guo, B Li, H Ma, X Wang, P Cai, Q Yu, L Zhu, L Jin… - BioRxiv, 2020 - biorxiv.org
ABSTRACT Coronavirus disease 2019 (COVID-19) has caused more than 40,000 deaths worldwide. Approximately 14% of patients with COVID-19 experienced severe disease and …
N Huot, C Planchais, P Rosenbaum, V Contreras… - Nature …, 2023 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA generally becomes undetectable in upper airways after a few days or weeks postinfection. Here we used a …
Z Zhou, L Ren, LI Zhang, J Zhong, Y Xiao, Z Jia, L Guo… - 2020 - papers.ssrn.com
The outbreaks of 2019 novel coronavirus disease (COVID-19) caused by SARS-CoV-2 infection has posed a severe threat to global public health. It is unclear how the human …
Coordinated local mucosal and systemic immune responses following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection either protect against …
Abstract Analysis of human blood immune cells provides insights into the coordinated response to viral infections such as severe acute respiratory syndrome coronavirus 2, which …
R Edahiro, Y Shirai, Y Takeshima, S Sakakibara… - Nature …, 2023 - nature.com
Mechanisms underpinning the dysfunctional immune response in severe acute respiratory syndrome coronavirus 2 infection are elusive. We analyzed single-cell transcriptomes and T …
COVID-19 exhibits extensive patient-to-patient heterogeneity. To link immune response variation to disease severity and outcome over time, we longitudinally assessed circulating …
Acute respiratory distress syndrome (ARDS) is a life-threatening syndrome, constituted by respiratory failure and diffuse alveolar damage that results from dysregulated local and …